Novartis introduces Lucentis® in state of the art pre-filled syringe

Novartis has announced the launch of the Lucentis® (ranibizumab) pre-filled syringe (PFS) in Germany, with other markets to follow throughout 2014. The Lucentis PFS, which received European approval in October 2013, is a new way of administering Lucentis that is specifically designed for intraocular injection to enhance patient safety and convenience for the treating clinician.
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: Industry News Ophthalmology Latest News Source Type: news